Head-to-head comparison of 18 F-FP-CIT and 123 I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts

(2017) Usman Saeed et al.   Translational Neurodegeneration

Relationship between [123I]-FP-CIT SPECT and clinical progression in Parkinson's disease

(2016) L. Ramani et al.   ACTA NEUROLOGICA SCANDINAVICA

Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using18F-FP-CIT

(2016) Hongyoon Choi et al.   HUMAN BRAIN MAPPING

Cerebellar role in Parkinson's disease

(2016) Jasmine L. Mirdamadi   JOURNAL OF NEUROPHYSIOLOGY

Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice

(2015) Fang Ba et al.   PARKINSONISM & RELATED DISORDERS

[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis

(2014) F. Brigo et al.   EUROPEAN JOURNAL OF NEUROLOGY

CT-Based Attenuation Correction in I-123-Ioflupane SPECT

(2014) Catharina Lange et al.   PLoS One

Quantitative Evaluation of Striatal I-123-FP-CIT Uptake in Essential Tremor and Parkinsonism

(2011) Gemma Cuberas-Borrós et al.   CLINICAL NUCLEAR MEDICINE

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases

(2011) Friederike Sixel-Döring et al.   JOURNAL OF NEUROLOGY

SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0

(2011) D. S. W. Djang et al.   JOURNAL OF NUCLEAR MEDICINE

Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls

(2008) S. A. Eshuis et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Technology Insight: imaging neurodegeneration in Parkinson's disease

(2008) David J Brooks   Nature clinical practice. Neurology